Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial

J Thorac Cardiovasc Surg. 2006 Sep;132(3):699-700. doi: 10.1016/j.jtcvs.2006.04.034.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Antibodies / blood
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Arginine / analogs & derivatives
  • Cardiopulmonary Bypass*
  • Female
  • Heparin / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Pipecolic Acids / therapeutic use*
  • Postoperative Care
  • Sulfonamides
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / immunology

Substances

  • Antibodies
  • Anticoagulants
  • Pipecolic Acids
  • Sulfonamides
  • Heparin
  • Arginine
  • argatroban